Safety and Efficacy of Albuterol in a Dry Powder Inhaler and an HFA MDI
Study Title
- A Cumulative Dose Study to Evaluate the Safety and Efficacy of Albuterol in a Dry Powder Inhaler and an HFA MDI (Hydrofluoroalkane Metered Dose Inhaler)
Teva Identifier
- ABS-AS-101
ClinicalTrials.gov Identifier
- NCT01056159
Study Status
- Completed
Trial Condition(s)
- Asthma
Interventions
- Drug: Albuterol dry powder inhaler | Drug: Albuterol HFA MDI (hydrofluoroalkane metered dose inhaler)
Study Description
- Please refer to ClinicalTrials.gov for a description of the trial
Key Participation Requirements
Gender
- Female, Male
Age Range
- 18 Years to 45 Years
Trial Duration
- 01/01/2010 - 06/01/2010
Phase
- Phase 1
Study Type
Interventional
